Global site English

NYSE: TRIO 61.84 down −0.47 (−0.75%) Close 2 Nov 2026

NYSE: TRIO USD

61.84

down −0.47 (−0.75%)

Close, 2 November 2026, 4:00 p.m. EST. Delayed data, for information only.

TriOptimum share price, last twelve months (NYSE: TRIO, USD) Line chart of TriOptimum's daily closing share price from 3 Nov 2025 to 2 Nov 2026. The price rose from 71.40 dollars to a high of 85.11 on 6 Aug 2026, fell sharply in the week of 19 October 2026 to a low of 57.10 on 21 Oct 2026, and closed at 61.84. 50.00 60.00 70.00 80.00 90.00 DecJan 26FebMarAprMayJunJulAugSepOctNov
52-week high 85.11 52-week low 57.10 12-month change -13.4%
Exchange
New York Stock Exchange
Ticker
TRIO
CUSIP
89628R105
ISIN
US89628R1059
Shares outstanding
1,214,306,512at 30 June 2026
Market capitalisation
$75.1 billionat close, 2 November 2026
Transfer agent
Harrowgate Shareholder Services
Fiscal year end
31 December
Quarterly cash dividends per share, US dollars.
DeclaredEx-dividendPaidAmount
2026-09-242026-10-092026-11-06$0.52
2026-06-252026-07-102026-08-07$0.52
2026-03-262026-04-102026-05-08$0.52
2025-12-112026-01-092026-02-06$0.52

TriOptimum has paid a dividend every year since 1967 and has increased it in 41 of the last 45 years. The dividend payable on 6 November 2026 was declared on 24 September 2026. The next declaration is expected in December.

Dividends are declared at the discretion of the Board. Registered shareholders can have dividends paid directly to a bank account or reinvested through the transfer agent’s dividend reinvestment plan.

Last closing price of each month, US dollars. November 2026 to date.
MonthLast trading dayClose
November 20262026-11-0261.84
October 20262026-10-3062.31
September 20262026-09-3079.76
August 20262026-08-3181.60
July 20262026-07-3183.40
June 20262026-06-3079.14
May 20262026-05-2979.57
April 20262026-04-3077.63
March 20262026-03-3176.47
February 20262026-02-2776.05
January 20262026-01-3075.08
December 20252025-12-3173.24
November 20252025-11-2871.80

TriOptimum is covered by 17 sell-side analysts. Their opinions, estimates and forecasts are their own and do not represent those of TriOptimum or its management. TriOptimum does not publish consensus estimates or endorse any analyst’s work. A list of covering firms is available from Investor Relations.